VRDNViridian Therapeutics, Inc.\DEvs its industry peers
A metric-by-metric comparison of Viridian Therapeutics, Inc.\DE against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Company | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| VRDNThis | $2.8B#8 | — | 4.3x#5 | 40.2x#6 | 23359.9%#1 | -26.9%#9 | -512.9%#6 | -51.7%#10 | -54.5%#5 | — | 8.6%#2 | — |
| DYN | $3.4B#1 | — | 4.8x#8 | — | — | -40.6%#12 | — | -0.0%#2 | -1301.5%#9 | — | — | — |
| VKTX | $3.3B#2 | — | 5.7x#12 | — | — | -227.1%#15 | — | -61.1%#12 | — | — | — | — |
| ELVN | $3.3B#3 | — | 3.7x#4 | — | — | -16.5%#7 | — | -11.6%#4 | — | — | — | — |
| AMLX | $3.3B#4 | — | 13.6x#14 | — | -100.0%#9 | 52.0%#4 | — | -60.5%#11 | — | — | — | — |
| IRON | $3.1B#5 | — | 4.8x#9 | — | — | -94.0%#13 | — | -32.9%#8 | -39.0%#4 | — | — | — |
| BHC | $3.0B#6 | — | — | 0.3x#1 | 6.7%#5 | 441.3%#1 | 17.7%#2 | — | 3.7%#2 | — | — | 11.7%#1 |
| IDYA | $3.0B#7 | — | 2.8x#2 | 13.8x#3 | 3024.4%#2 | 58.6%#3 | -72.8%#3 | -10.4%#3 | — | — | — | — |
| NRIX | $2.8B#9 | 10.6x#1 | 2.9x#3 | 33.6x#5 | 54.0%#3 | -36.6%#10 | -340.2%#5 | -27.3%#7 | — | — | 104.8%#1 | — |
| MBX | $2.7B#10 | — | 6.5x#13 | — | — | -40.5%#11 | — | -21.2%#6 | — | — | — | — |
| RCUS | $2.4B#11 | — | 5.2x#10 | 73.0x#7 | -35.3%#8 | -24.7%#8 | -1169.7%#7 | -76.1%#14 | -93.0%#8 | — | — | — |
| PBH | $2.3B#12 | 13.9x#2 | 1.2x#1 | 2.2x#2 | -4.3%#6 | -11.3%#6 | 28.4%#1 | 9.9%#1 | 5.9%#1 | 4#1 | -18.2%#3 | — |
| IMNM | $2.3B#13 | — | 4.4x#6 | 332.7x#8 | -23.2%#7 | 27.5%#5 | -3228.8%#8 | -40.4%#9 | -72.8%#7 | — | — | — |
| XNCR | $2.3B#14 | — | 4.5x#7 | 18.2x#4 | 13.7%#4 | 60.5%#2 | -141.4%#4 | -18.3%#5 | -31.5%#3 | — | — | — |
| VERA | $2.2B#15 | — | 5.4x#11 | — | — | -96.9%#14 | — | -73.5%#13 | -72.7%#6 | — | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. This table timed out mid-build, so it covers part of the group; ranks are within the rows shown and it fills in shortly. Table built 2026-11-04.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice